GATA3 and mature T-cell and NK-cell non-Hodgkin lymphoma: The demonstration that current treatment paradigms are largely futile, at least in GATA-3 expressing PTCL, further supports GATA-3’s utility as both a diagnostic and prognostic biomarker.